Assessing the clinical value of fast onset and sustained duration of action of long-acting bronchodilators for COPD.

导出 LinkOut

翻译打印收藏纠错

第一作者： Mario,Cazzola

第一单位： Unit of Respiratory Clinical Pharmacology, Department of Systems Medicine, and Postgraduate School of Respiratory Medicine, University of Rome 'Tor Vergata', Via Montpellier 1, 00133, Rome, Italy. Electronic address: mario.cazzola@uniroma2.it.

作者： Mario,Cazzola ^[1] ; Kai M,Beeh ^[2] ; David,Price ^[3] ; Nicolas,Roche ^[4]

作者单位： Unit of Respiratory Clinical Pharmacology, Department of Systems Medicine, and Postgraduate School of Respiratory Medicine, University of Rome 'Tor Vergata', Via Montpellier 1, 00133, Rome, Italy. Electronic address: mario.cazzola@uniroma2.it. ^[1] Insaf Respiratory Research Institute, Biebricher Allee 34, D-65187 Wiesbaden, Germany. Electronic address: k.beeh@insaf-wi.de. ^[2] Academic Primary Care, Division of Applied Health Sciences, University of Aberdeen, Polwarth Building, Aberdeen AB25 2ZD, UK. Electronic address: dprice@rirl.org. ^[3] Service de Pneumologie AP-HP, University Paris Descartes (EA2511), Groupe Hospitalier Cochin, HIA du Val de Grâce 4e C, 74 Bd de Port Royal, F-75005 Paris, France. Electronic address: nicolas.roche@cch.aphp.fr. ^[4]

关键词 Adherence Beta-2 adrenergic agonists Chronic obstructive pulmonary disease Long-acting bronchodilators Muscarinic antagonists Onset of action